Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma
Bertrand Le Roy(Centre Hospitalier Universitaire de Saint-Étienne), António Sá Cunha(Assistance Publique – Hôpitaux de Paris), Gabriella Pittau(Université Paris-Saclay), Maximiliano Gelli(Université Paris-Saclay), Daniel Cherqui(Assistance Publique – Hôpitaux de Paris), Marc‐Antoine Allard(Assistance Publique – Hôpitaux de Paris), René Adam(Assistance Publique – Hôpitaux de Paris), Éric Vibert(Inserm), D. Castaing(Assistance Publique – Hôpitaux de Paris), Badr Serji(Assistance Publique – Hôpitaux de Paris)
Cited by 255
Related Papers
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
|The Lancet. Gastroenterology & hepatology|2020|602
Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus
|Cancer Treatment Reviews|2015|596